Alteration in plasma protein binding properties of propranolol and flurbiprofen during development of adjuvant-induced arthritis in rats

References

• Abramson FP, Jenkins J, Ostchega Y. (1982). Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding. Clin Pharmacol Ther 32:659–663.
   PubMed Web of Science ®Google Scholar
• Aguirre C, Trocóniz IF, Valdivieso A, Jiménez RM, González JP, Calvo R, Rodríguez-Sasiaín JM. (1996). Pharmacokinetics and pharmacodynamics of penbutolol in healthy and cancer subjects: role of altered protein binding. Res Commun Mol Pathol Pharmacol 92:53–72.
   PubMed Web of Science ®Google Scholar
• Belpaire FM, Bogaert MG, Rosseneu M. (1982). Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum. Eur J Clin Pharmacol 22:253–256.
   PubMed Web of Science ®Google Scholar
• Belpaire FM, Braeckman RA, Bogaert MG. (1984). Binding of oxprenolol and propranolol to serum, albumin and alpha 1-acid glycoprotein in man and other species. Biochem Pharmacol 33:2065–2069.
   PubMed Web of Science ®Google Scholar
• Belpaire FM, de Smet F, Chindavijak B, Fraeyman N, Bogaert MG. (1989). Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat. Fundam Clin Pharmacol 3:79–88.
   PubMed Web of Science ®Google Scholar
• Birch HE, Schreiber G. (1986). Transcriptional regulation of plasma protein synthesis during inflammation. J Biol Chem 261:8077–8080.
   PubMed Web of Science ®Google Scholar
• Bishop H, Schneider RE, Welling PG. (1981). Plasma propranolol concentrations in rats with adjuvant-induced arthritis. Biopharm Drug Dispos 2:291–297.
   PubMed Web of Science ®Google Scholar
• Cai X, Wong YF, Zhou H, Xie Y, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L. (2006). The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis. Naunyn Schmiedebergs Arch Pharmacol 373:140–147.
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Amisaki T. (2006). Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids. Proteins 64:730–739.
   PubMed Web of Science ®Google Scholar
• Heegaard PM. (1992). Changes in serum glycoprotein glycosylation during experimental inflammation in mice are general, unrelated to protein type, and opposite changes in man and rat: studies on mouse serum alpha 1-acid glycoprotein, alpha 1-esterase, and alpha 1-protease inhibitor. Inflammation 16:631–644.
   Google Scholar
• Huang JD, Oie S. (1985). Influence of serum protein binding on hepatic clearance of S-disopyramide in the rabbit. J Pharm Pharmacol 37:471–475.
   PubMed Web of Science ®Google Scholar
• Kremer JM, Wilting J, Janssen LH. (1988). Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 40:1–47.
   PubMed Web of Science ®Google Scholar
• Laethem ME, Belpaire FM, Wijnant P, Rosseel MT, Bogaert MG. (1994). Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat. Chirality 6:405–410.
   PubMed Web of Science ®Google Scholar
• Le Gal JM, Manfait M. (1990). Conformational changes of human serum albumin in vivo induced by free fatty acids as studied by Fourier transform infrared spectroscopy. Biochim Biophys Acta 1041:257–263.
   Google Scholar
• Mackiewicz A, Ganapathi MK, Schultz D, Kushner I. (1987). Monokines regulate glycosylation of acute-phase proteins. J Exp Med 166:253–258.
   PubMedGoogle Scholar
• Mackiewicz A, Kushner I. (1989). Interferon beta 2/B-cell stimulating factor 2/interleukin 6 affects glycosylation of acute phase proteins in human hepatoma cell lines. Scand J Immunol 29:265–271.
   Google Scholar
• Mackiewicz A, Mackiewicz K. (1995). Glycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer. Glycoconj J 12:241–247.
   PubMed Web of Science ®Google Scholar
• Makni M, Chtourou Y, Fetoui H, Garoui el M, Boudawara T, Zeghal N. (2011). Evaluation of the antioxidant, anti-inflammatory and hepatoprotective properties of vanillin in carbon tetrachloride-treated rats. Eur J Pharmacol 668:133–139.
   PubMed Web of Science ®Google Scholar
• Marinkovic S, Jahreis GP, Wong GG, Baumann H. (1989). IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 142:808–812.
   PubMed Web of Science ®Google Scholar
• Mayo PR, Skeith K, Russell AS, Jamali F. (2000). Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis. Br J Clin Pharmacol 50:605–613.
   PubMed Web of Science ®Google Scholar
• Miyoshi M, Sakaki H, Usami M, Iizuka N, Shuno K, Aoyama M, Usami Y. (2011). Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats. Clin Nutr 30:252–258.
   Google Scholar
• Piafsky KM, Borgá O, Odar-Cederlöf I, Johansson C, Sjöqvist F. (1978). Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med 299:1435–1439.
   PubMed Web of Science ®Google Scholar
• Piquette-Miller M, Jamali F. (1992). Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats. Agents Actions 37:290–296.
   PubMedGoogle Scholar
• Piquette-Miller M, Jamali F. (1993). Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay. Pharm Res 10:294–299.
   PubMed Web of Science ®Google Scholar
• Piquette-Miller M, Jamali F. (1995). Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis. Drug Metab Dispos 23:240–245.
   PubMed Web of Science ®Google Scholar
• Pollock SH, Matthews HW, D’Souza MJ. (1989). Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats. Drug Metab Dispos 17:595–599.
   PubMed Web of Science ®Google Scholar
• Poüs C, Chauvelot-Moachon L, Lecoustillier M, Durand G. (1992). Recombinant human interleukin 1 beta and tumor necrosis factor affect glycosylation of serum alpha 1-acid glycoprotein in rats. Inflammation 16:197–203.
   Google Scholar
• Rodriguez M, Ortega I, Soengas I, Leal N, Suarez E, Calvo R, Lukas JC. (2004). Alpha-1-acid glycoprotein directly affects the pharmacokinetics and the analgesic effect of methadone in the rat beyond protein binding. J Pharm Sci 93:2836–2850.
   PubMed Web of Science ®Google Scholar
• Sahreen S, Khan RM, Khan AR. (2011). Hepatoprotective effects of methanol extract of Carissa opaca leaves on CCl4-induced damage in rat. BMC Complement Altern Med, 11:1–9.
   PubMed Web of Science ®Google Scholar
• Schneider RE, Bishop H, Kendall MJ, Quarterman CP. (1981). Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents. Int J Clin Pharmacol Ther Toxicol 19:158–162.
   PubMedGoogle Scholar
• Sharma RJ, Macallan DC, Sedgwick P, Remick DG, Griffin GE. (1992). Kinetics of endotoxin-induced acute-phase protein gene expression and its modulation by TNF-alpha monoclonal antibody. Am J Physiol 262:R786–R793.
   PubMed Web of Science ®Google Scholar
• Uno S, Fujii A, Komura H, Kawase A, Iwaki M. (2008). Prediction of metabolic clearance of diclofenac in adjuvant-induced arthritis rats using a substrate depletion assay. Xenobiotica 38:482–495.
   PubMed Web of Science ®Google Scholar
• van Dijk W, Pos O, van der Stelt ME, Moshage HJ, Yap SH, Dente L, Baumann P, Eap CB. (1991). Inflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice. Biochem J 276 (Pt 2):343–347.
   Google Scholar
• Walker KA, Barber HE, Hawksworth GM. (1986). Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat. Drug Metab Dispos 14:482–486.
   PubMed Web of Science ®Google Scholar
• Williams RC Jr. (1992). Rheumatoid factors: historical perspective, origins and possible role in disease. J Rheumatol Suppl 32:42–45.
   PubMedGoogle Scholar